Fatemeh Karimi Dermani

Statistics

Publications

Citations

255

H-Index

Active since

2016

Affiliations

Hamedan University of Medical Sciences(Current)

Shariati Hospital

Tehran University of Medical Sciences

Fatemeh Karimi Dermani is an author at Hamedan University of Medical Sciences specializing in oncology, molecular oncology, and microrna function in cancer.

Publications per year

2016–2021

Publications

Resveratrol Inhibits Proliferation, Invasion, and Epithelial–Mesenchymal Transition by Increasing miR‐200c Expression in HCT‐116 Colorectal Cancer Cells

Fatemeh Karimi Dermani, Massoud Saidijam, Razieh Amini et al. · Journal of Cellular Biochemistry · 2016 · 94 citations

Medicine, Cancer Biology, Oncology +17

<i>Retracted</i>: Zerumbone inhibits epithelial‐mesenchymal transition and cancer stem cells properties by inhibiting the β‐catenin pathway through miR‐200c

Fatemeh Karimi Dermani, Razieh Amini, Massoud Saidijam et al. · Journal of Cellular Physiology · 2018 · 42 citations

Medicine, Oncology, Pharmacology +17

The Effect of miR-200c Inhibition on Chemosensitivity (5- FluoroUracil) in Colorectal Cancer

Korosh Heydari, Massoud Saidijam, Mohammadreza Sharifi et al. · Pathology & Oncology Research · 2017 · 38 citations

Medicine, Oncology, Pharmacology +16

DCLK1 plays an important role in colorectal cancer tumorgenesis through the regulation of miR-200c

Yasaman Mohammadi, Seyed Mohammad Tavangar, Massoud Saidijam et al. · Biomedicine & Pharmacotherapy · 2018 · 30 citations

Medicine, Molecular Biology, Oncology +13

Bacterial Multidrug Efflux Proteins: A Major Mechanism of Antimicrobial Resistance

Irshad Ahmad, Nighat Nawaz, Fatemeh Karimi Dermani et al. · Current Drug Targets · 2018 · 23 citations

Life Sciences, Microbiology, Molecular Biology +16

1–5 of 7